My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 26 Nov 2009 | 16:30 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated (LGND.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
LGND
on other exchanges
As of 25 Nov 2009
2.02
USD
Price Change
-0.11
Percent Change
-5.16%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Berkman, Charles
40
2007
Vice President, General Counsel, Secretary
Meglasson, Martin
59
2004
Vice President - Discovery Research
Kazmi, Syed
52
2007
Vice President - Business Development and Strategic Planning
Higgins, John
39
2007
President,Chief Executive Officer, Director
Aryeh, Jason
40
2006
Director
Knott, David
63
2007
Director
Davis, Todd
47
2007
Director
Sabba, Stephen
49
2008
Director
Burakoff, Steven
66
2008
Director
Sharp, John
44
2007
Chief Financial Officer, Vice President - Finance
Kozarich, John
58
2007
Chairman of the Board
Find out more about LGND.O
Insider Trading